Yasuhiro Watanabe1, Takashi Yamaguchi2, Shuhei Yamaoka2, Kazuki Abe2, Hiroki Onda2, Shoko Nakamura2, Sho Tanaka2, Takashi Oshiro3, Masahiro Ohira4, Daiji Nagayama2,5, Naomi Shimizu2, Ichiro Tatsuno2,6, Atsuhito Saiki2. 1. Center of Diabetes, Endocrinology and Metabolism, Toho University Sakura Medical Center, Sakura-shi, Japan, y.watanabe1216@gmail.com. 2. Center of Diabetes, Endocrinology and Metabolism, Toho University Sakura Medical Center, Sakura-shi, Japan. 3. Department of Surgery, Toho University Sakura Medical Center, Sakura-shi, Japan. 4. Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Japan. 5. Nagayama Clinic, Oyama-shi, Japan. 6. Chiba Prefectural University of Health Sciences, Mihama-ku, Japan.
Abstract
INTRODUCTION: In patients with severe obesity, albuminuria can be improved by both conventional medical therapy and bariatric surgery. The purpose of this study was to compare the impact of weight loss achieved through conventional medical therapy or laparoscopic sleeve gastrectomy (LSG) on albuminuria in Japanese subjects with severe obesity and identify the factors involved. METHODS: We retrospectively evaluated the clinical characteristics including the urinary albumin/creatinine ratio (UACR) of 340 consecutive subjects with a body mass index ≥35 who received LSG (n = 242) or medical therapy (n = 98) between 2010 and 2018 and were followed for at least 12 months. RESULTS: The baseline of the UACR was not different between the 2 groups. At the 12-month follow-up, total weight loss (TWL) and decreases in glycosylated hemoglobin (HbA1c) and loge UACR were greater in the LSG group than in the medical therapy group (body weight; -35.7 kg vs. -8.0 kg, p < 0.001, HbA1c; -1.4% vs. -0.7%, p < 0.001, loge UACR; -0.3 vs. 0.9, p < 0.001). The rate of complete remission of diabetes was significantly higher in the LSG group than in the medical therapy group. At 12 and 36 months (n = 111 in the medical therapy group, n = 56 in the LSG group at 36 months), loge UACR increased in the medical therapy group, while it remained unchanged or decreased in the LSG group. In subjects with microalbuminuria and macroalbuminuria, changes in the loge UACR correlated with percent total body weight loss (%TWL) in both groups at 12 months. Percent TWL contributed independently to the change in the loge UACR, irrespective of whether LSG was performed. In receiver-operating characteristic analysis, a weight loss of 7.8% predicted a decrease in the UACR (∆UACR <0 at 12 months). CONCLUSION: Our analysis suggests that albuminuria may increase over time if only medical therapy is continued. To improve albuminuria, weight loss may be more important than whether LSG is performed.
INTRODUCTION: In patients with severe obesity, albuminuria can be improved by both conventional medical therapy and bariatric surgery. The purpose of this study was to compare the impact of weight loss achieved through conventional medical therapy or laparoscopic sleeve gastrectomy (LSG) on albuminuria in Japanese subjects with severe obesity and identify the factors involved. METHODS: We retrospectively evaluated the clinical characteristics including the urinary albumin/creatinine ratio (UACR) of 340 consecutive subjects with a body mass index ≥35 who received LSG (n = 242) or medical therapy (n = 98) between 2010 and 2018 and were followed for at least 12 months. RESULTS: The baseline of the UACR was not different between the 2 groups. At the 12-month follow-up, total weight loss (TWL) and decreases in glycosylated hemoglobin (HbA1c) and loge UACR were greater in the LSG group than in the medical therapy group (body weight; -35.7 kg vs. -8.0 kg, p < 0.001, HbA1c; -1.4% vs. -0.7%, p < 0.001, loge UACR; -0.3 vs. 0.9, p < 0.001). The rate of complete remission of diabetes was significantly higher in the LSG group than in the medical therapy group. At 12 and 36 months (n = 111 in the medical therapy group, n = 56 in the LSG group at 36 months), loge UACR increased in the medical therapy group, while it remained unchanged or decreased in the LSG group. In subjects with microalbuminuria and macroalbuminuria, changes in the loge UACR correlated with percent total body weight loss (%TWL) in both groups at 12 months. Percent TWL contributed independently to the change in the loge UACR, irrespective of whether LSG was performed. In receiver-operating characteristic analysis, a weight loss of 7.8% predicted a decrease in the UACR (∆UACR <0 at 12 months). CONCLUSION: Our analysis suggests that albuminuria may increase over time if only medical therapy is continued. To improve albuminuria, weight loss may be more important than whether LSG is performed.
Authors: A Saiki; D Nagayama; M Ohhira; K Endoh; M Ohtsuka; N Koide; T Oyama; Y Miyashita; K Shirai Journal: Int J Obes (Lond) Date: 2005-09 Impact factor: 5.095
Authors: Johanna Maria Brix; Carsten Thilo Herz; Hans Peter Kopp; Astrid Feder; Eva-Christina Krzizek; Christoph Sperker; Gerit-Holger Schernthaner; Guntram Schernthaner; Bernhard Ludvik Journal: Obes Surg Date: 2019-11 Impact factor: 4.129
Authors: Aminu K Bello; Dick de Zeeuw; Meguid El Nahas; Auke H Brantsma; Stephan J L Bakker; Paul E de Jong; Ronald T Gansevoort Journal: Nephrol Dial Transplant Date: 2007-03-14 Impact factor: 5.992
Authors: LeAnne Young; Zubaidah Nor Hanipah; Stacy A Brethauer; Philip R Schauer; Ali Aminian Journal: Surg Endosc Date: 2018-09-24 Impact factor: 4.584
Authors: Mark Guy; Joanna K Borzomato; Ronald G Newall; Philip A Kalra; Christopher P Price Journal: Ann Clin Biochem Date: 2009-09-03 Impact factor: 2.057
Authors: Aoife L Canney; Ricardo V Cohen; Jessie A Elliott; Cristina M Aboud; William P Martin; Neil G Docherty; Carel W le Roux Journal: Diab Vasc Dis Res Date: 2019-11-14 Impact factor: 3.291